HSS and Fit:match collaborate to bring ai-powered body scanning and movement education to TCS New York City Marathon runners. Hospital for Special Surgery Fit:match AI body intelligence platform body composition marathon runners QuadraScan NEW YORK-(BUSINESS WIRE)-After months of training, marathon runners know their pace, mileage and target finish time. Hospital for Special Surgery (HSS) and Fit:match, the AI body intelligence platform, are collaborating to help them see another dimension of their preparation: their body composition. Runners visiting the 2026 TCS New York City Marathon Expo Presented by New Balance at the Jacob K. Javits Convention Center can visit the HSS x Fit:match booth for a 3D body-scanning and educational experience powered by Fit:match's QuadraScan technology. From October 29 through October 31, runners visiting the 2026 TCS New York City Marathon Expo Presented by New Balance at the Jacob K. Javits Convention Center can visit the HSS x Fit:match booth for a 3D body-scanning and educational experience powered by Fit:match's QuadraScan technology. The activation offers runners access to scan-derived body measurements and educational information at an Expo where nearly 60,000 runners will collect their bibs ahead of race day. Using just four photos captured in under ten seconds, QuadraScan generates estimates of lean mass, fat mass and bone mineral content. Scan-derived measurements and estimates are delivered through the Fit:match mobile app, giving runners a starting point for learning more about their body composition in the context of training and recovery. "Runners put months of dedication into preparing for the marathon, but pace and mileage tell only part of their story," said Pam Geisel, Director of Performance & Wellness. "Through this collaboration, we're giving runners a deeper understanding of the bodies carrying them across the finish line and giving them educational insights they can carry into their next training cycle." The experience combines HSS's expertise in fitness, movement, and running education with Fit:match's AI technology to make body composition insights accessible at a defining moment in each runner's journey. With subsequent scans, runners can compare future scan-derived measurements to their Expo baseline to see how those measurements may change over time. "Every runner arrives at the starting line with a different body and a different training story. We believe their experience should be just as personal," said Haniff Brown, founder and CEO of Fit:match. "Together with HSS, we're giving runners a body blueprint that goes beyond weight - it's a baseline they can return to over time as they recover, allowing them to compare future scan-derived measurements and better understand how these measurements evolve." Google is supporting the activation as a technology collaborator, providing dedicated GPU infrastructure on site to power QuadraScan's AI processing. The infrastructure is designed to keep results moving quickly as runners visit the booth throughout the three-day Expo. Runners can visit the HSS x Fit:match booth at the 2026 TCS New York City Marathon Expo Presented by New Balance, October 29-31, at the Jacob K. Javits Convention Center, 429 11th Avenue, New York, NY 10001. About Fit:match Fit:match is the world's leading AI platform for body insights, using advanced computer vision to turn a 10-second mobile scan into real-world body intelligence. Its flagship product, QuadraScan, delivers accurate measurements, shape and composition indicators, and hyper-realistic 3D avatars, with no specialized hardware, making body data instantly scalable across healthcare, sports, and 3D design. In healthcare settings, QuadraScan gives clinicians and care teams consistent, measurable body composition data to support patient monitoring and outcomes, replacing subjective assessments with data that's accurate, actionable, and easy to track over time. The Fit:match QuadraScan app is available for download here. HSS is the world's leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 17th consecutive year), No. 3 in rheumatology by U.S. News & World Report (2026-2027), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report "Best Children's Hospitals" list (2026-2027). HSS is the worlds most awarded hospital in orthopedics by Newsweek each year since the "World's Best Specialized Hospitals" survey was introduced in 2020. Founded in 1863, the Hospital has the lowest readmission rate in the nation, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center six consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnose, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu Hillary Baccaro Head of Marketing, Fit:match AI [email protected] The De Angelis Group | Orthopedics This Week | MSK Innovations Why This Matters Two perspectives. MBA Lens: Economic and industry impact. Hospital for Special Surgery (HSS) and Fit:match are strategically collaborating to offer AI-powered body scanning to marathon runners at the TCS New York City Marathon Expo. This initiative leverages Fit:match's QuadraScan technology to provide personalized body composition insights, enhancing runner engagement and HSS's brand presence in sports medicine. The free service aims to drive adoption of Fit:match's platform and establish a baseline for ongoing runner health tracking. * The collaboration targets a large, health-conscious consumer base at a major event for market penetration and brand differentiation. * Google's support for GPU infrastructure highlights the technological investment in scalable, real-time data processing for mass adoption. PhD Lens: Clinical and outcomes impact. The collaboration introduces Fit:match's QuadraScan technology, an AI-powered 3D body scanning system, to marathon runners. This system utilizes four photos to generate estimates of lean mass, fat mass, and bone mineral content, delivered via a mobile app. The primary mechanism is to provide personalized body composition insights, enabling runners to track changes over time for training and recovery purposes, establishing a baseline for future comparisons. * QuadraScan estimates body composition parameters (lean mass, fat mass, bone mineral content) from photographic input. * The technology offers a non-invasive method for longitudinal tracking of body composition changes relevant to athletic performance and recovery. Discussion. Dr. Sarah Mitchell Orthopedic Surgeon · Mayo Clinic This is a fascinating development. In my practice Orthopedics This Week Inc. has seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds? James Thornton, MD Spine Fellow · HSS Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT. R. Patel Sports Medicine · Stanford Orthopedics This Week Inc. implemented a similar approach last year. Early results are promising but Orthopedics This Week Inc. is still gathering 12-month follow-up data. Happy to share its protocol if anyone is interested. Join the conversation. Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

HSS study finds robotic-assisted lumbar fusion associated with lower opioid use after surgery. Newswise - San Antonio, TX, October 15, 2026 - Patients who underwent robotic-assisted minimally invasive lumbar fusion surgery required significantly less opioid medication during their hospital stay, without increased complications or longer hospital stays, compared with patients treated using conventional navigation-guided techniques, according to research presented by Hospital for Special Surgery (HSS) at the North American Spine Society (NASS) Annual Meeting. The study, Comparison of Opioid Utilization After Robotic Arm-Assisted and Navigation-Guided Minimally Invasive Transforaminal Lumbar Interbody Fusion (MIS-TLIF), evaluated 804 patients who underwent one- or two-level lumbar fusion procedures between 2017 and 2025. Researchers found that patients whose surgeries were performed with robotic arm guidance used 16% less opioid medication during their hospitalization and were significantly less likely to require intravenous patient-controlled analgesia (PCA), a stronger form of pain management. The findings come at a time when spine surgeons continue seeking ways to reduce opioid exposure while maintaining effective postoperative pain control. "Reducing patients' exposure to opioid medications after surgery remains an important goal in spine care," said Sheeraz A. Qureshi, MD, MBA, Co-Chief of HSS Spine and co-author of the study. "While robotic technology is often recognized for improving surgical precision, these results suggest its benefits may extend beyond the operating room." Minimally invasive transforaminal lumbar interbody fusion commonly uses advanced imaging and navigation systems to guide the placement of spinal implants. Robotic arm-assisted platforms build upon those technologies by providing additional stability and precision during surgery. While previous studies have largely focused on implant placement accuracy and surgical efficiency, less has been known about whether robotic assistance influences postoperative pain management. Using a prospectively maintained spine surgery registry, investigators compared outcomes among 203 patients who underwent navigation-guided surgery and 601 patients who underwent robotic-assisted procedures. After accounting for differences in patient characteristics, surgeons and other factors, the robotic-assisted group consistently demonstrated lower opioid utilization. Key findings included: * 16% reduction in total in-hospital opioid consumption among patients who underwent robotic-assisted surgery * 21% reduction in opioid use during the first 24 hours after surgery * 57% reduction in the likelihood of requiring PCA pain medication * No significant differences in complications or hospital length of stay "We observed a consistent reduction in opioid utilization among patients who underwent robotic-assisted surgery, including lower overall opioid consumption and substantially less need for intravenous patient-controlled analgesia," said Kyle W. Morse, MD, spine surgeon at HSS and co-author of the study. "Importantly, these reductions occurred while maintaining similar safety outcomes. These findings suggest robotic guidance may offer meaningful benefits for patients recovering from lumbar fusion surgery and could play an important role in future opioid-sparing perioperative care pathways." The findings add to a growing body of evidence that robotic-assisted spine surgery may provide benefits beyond surgical precision, potentially helping reduce opioid exposure during recovery while maintaining comparable safety outcomes. HSS is the world's leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 17th consecutive year), No. 3 in rheumatology by U.S. News & World Report (2026-2027), and the best pediatric orthopedic hospital in NY, NJ and CT by U.S. News & World Report "Best Children's Hospitals" list (2026-2027). HSS is the worlds most awarded hospital in orthopedics by Newsweek each year since the "World's Best Specialized Hospitals" survey was introduced in 2020. Founded in 1863, the Hospital has the lowest readmission rate in the nation, and among the lowest infection and complication rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center six consecutive times. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State, as well as in Florida. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. In addition, more than 200 HSS clinical investigators are working to improve patient outcomes through better ways to prevent, diagnose, and treat orthopedic, rheumatic and musculoskeletal diseases. The HSS Education Institute is a trusted leader in advancing musculoskeletal knowledge and research for physicians, nurses, allied health professionals, academic trainees, and consumers in more than 165 countries. The institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally. www.hss.edu. Media Contacts: Tracy Hickenbottom/Rachael Rennich/Lizzy Keach Media contact. Related experts. Type of article. Section.

Hospital for Special Surgery (HSS), the world’s leading academic medical center specializing in musculoskeletal health, today announced a $21M Series A to launch RightMove Powered by HSS™, an independent for-profit company, whose mission is to make high quality, patient-focused virtual musculoskeletal physical therapy available to all Americ...